SARAH MORROW: Open Payments
NPI 1972118701 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,120 in 155 payments from 22 companies in 2025. Trend: 2023 $650 · 2024 $3,757 · 2025 $5,120
Food & beverage: $3,965Travel & lodging: $1,069Education: $85
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 7 | $1,644 |
| Janssen Biotech, Inc. | 19 | $502 |
| Lilly USA, LLC | 10 | $375 |
| Madrigal Pharmaceuticals | 10 | $344 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $313 |
| GENZYME CORPORATION | 11 | $311 |
| ABBVIE INC. | 23 | $304 |
| PFIZER INC. | 8 | $215 |
| QOL Medical, LLC | 8 | $208 |
| Ipsen Biopharmaceuticals, Inc | 6 | $159 |
Products named: TREMFYA, DUPIXENT, REZDIFFRA, OMVOH, VELSIPITY, Sucraid, ENTYVIO, IQIRVO.
Industry payments across MS — which companies pay providers there.
